➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Medtronic
Boehringer Ingelheim
Merck
Harvard Business School

Last Updated: May 29, 2020

DrugPatentWatch Database Preview

Almatica Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ALMATICA, and what generic alternatives to ALMATICA drugs are available?

ALMATICA has one approved drug.

There are seven US patents protecting ALMATICA drugs.

There are fifty-one patent family members on ALMATICA drugs in sixteen countries.

Summary for Almatica
International Patents:51
US Patents:7
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Almatica

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almatica GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 BX RX Yes Yes 7,438,927   Start Trial   Start Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 BX RX Yes Yes 8,252,332   Start Trial Y   Start Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 BX RX Yes Yes 6,488,962   Start Trial Y   Start Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 BX RX Yes Yes 8,192,756   Start Trial Y   Start Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 BX RX Yes Yes 7,731,989   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Almatica

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 6,340,475   Start Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 6,340,475   Start Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 6,635,280   Start Trial
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 6,635,280   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ALMATICA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 300 mg and 600 mg ➤ Subscribe 2011-10-31
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Express Scripts
Baxter
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.